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ABSTRAK 
Tarigan S, Sumarningsih. 2016. Potensi tes antigen dan tes serologi yang didasarkan pada epitope linier CNTKCQTP pada 
haemagglutinin H5N1 untuk Avian Influenza. JITV 21(1): 62-72. DOI: http://dx.doi.org/10.14334/jitv.v21i1.1251 
Alat diagnosa cepat atau point-of-care (POC) test sangat dibutuhkan dalam usaha pengendalian dan pemberantasan high 
pathogenic avian influenza (HPAI) H5N1 di Indonesia. Akurasi alat diagnosa POC ditentukan oleh spesifitas antibodi yang 
merupakan komponen utama dari semua alat diagnosis cepat. Baru-baru ini dilaporkan bahwa epitop CNTKCQTP yang terletak 
pada residu asam amino 274-281 protein hemaglutinin H5 hanya dimiliki oleh virus H5N1 dan semua clade virus subtipe H5N1 
memiliki epitop tersebut. Penelitian ini bertujuan memproduksi dan mengevaluasi spesifitas poliklonal antibodi terhadap epitope 
tersebut. Antibodi diproduksi dengan cara mengimunisasi kambing dengan peptida tersebut dalam bentuk multiple antigen 
peptide (MAP). Spesifitas antibodi diukur dengan cara menganalisis reaktivitasnya terhadap virus influenza subtipe H3N3, 
H4N4, H5N1, H6N5, H7N7, H9N2, H10N7 dan H11N9, dan rekombinan hemagglutinin H1-H12, H14 dan H15 dengan ELISA 
dan immunoblot. Hasil ELISA dan immunoblot menunjukkan bahwa antibodi CNTKCQTP tidak spesifik terhadap 
haemagglitinin H5 karena memiliki reaksi silang dengan haemgglutinin lain terutama H7, H8 dan H9. Potensi peptida yang 
mengandung epitop, GNCNTKCQTPMGAINSS. sebagai reagen ELISA untuk mengukur antibodi H5 pada ayam yang 
sebelumnya telah divaksin dan ditantang dengan virus H5N1 juga dievaluasi dalam penelitian ini. Berbeda dengan hasil peneliti 
sebelumnya, ELISA yang menggunakan peptida tersebut sebagai coating atau pelapis tidak sensitif mendeteksi antibody 
haemagglutinin H5 pada ayam. 
Kata Kunci: Virus AI, Hemagglutinin H5, Epitop CNTKCQTP, MAP, Immunoassay 
ABSTRACT 
Tarigan S, Sumarningsih. 2016. Potency of antigenic and serologic tests based on CNTKCQTP linear epitope on H5N1 
haemagglutinin for Avian Influenza. JITV 21(1): 62-72. DOI: http://dx.doi.org/10.14334/jitv.v21i1.1251 
Rapid diagnostic tools or point-of-care (POC) test is needed in the effort to control and eradicate the high pathogenic avian 
influenza (HPAI) H5N1 in Indonesia. Accuracy of a POC test is determined by the specificity of antibodies, which is the main 
component of a POC test. Recently a linear epitope, CNTCKQTP epitope, located at 274-281 amino acid residue of H5 
hemagglutinin has been confirmed to be present all clade of H5N1 viruses. This study aimed at producing and evaluating the 
reactivity of a monospecific, polyclonal antibody against the epitope. The Antibody was produced by immunizing a goat with 
the peptide in the form of multiple antigen peptide (MAP). The specificity of the antibody was estimated by assaying its 
reactivity against influenza virus subtypes H3N3, H4N4, H5N1, H6N5, H7N7, H9N2, H10N7 and H11N9; and recombinant 
hemagglutinins H1-H12, H14 and H15 with ELISA and immunoblot. The results of the assay showed that CNTKCQTP 
antibody was not specific for H5 haemagglitinin because it cross-reacted with other haemagglutinins especially H7, H8 and H9. 
The potential of the peptide containing the epitope, GNCNTKCQTPMGAINSS. as an ELISA reagent for assaying H5 antibodies 
in chickens previously vaccinated and challenged with the H5N1 virus was also evaluated in this study. In contrast the results of 
previous studies, the ELISA using GNCNTKCQTPMGAINSS as coating antigen was not sensitive in detecting antibody to 
haemagglutinin H5 in chickens. 
Key Words: AI Virus, Hemagglutinin H5, CNTKCQTP Epitope, MAP, Immunoassay 
INTRODUCTION 
In the early 2000s, highly pathogenic avian 
influenza (HPAI) H5N1 influenza was detected in many 
parts of the world causing concerns particularly after 
eighteen people were hospitalized, six of whom died, 
after contracting the H5N1 virus from infected chickens 
(Claas et al. 1998). Between December 2003 and 
January 2004, outbreaks of H5N1 sprang up 
simultaneously in eight countries in the East and 
Southeast Asia (Sims et al. 2005). Within three years, 
the disease has spread to 63 countries (FAO 2012) and 
caused death and culling of about 400 million domestic 
poultry globally with estimated  economic losses of 
about US $20 billion (FAO 2012). Most of the 63 
affected countries were able to eliminate H5N1 virus 
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rapidly except for China, Indonesia, Vietnam, India, 
Bangladesh and Egypt, where eradication of the disease 
proven to be difficult and subsequently has become 
endemic (FAO 2011).  
One of the most important factors for those 
countries that successfully eradicated H5N1 virus was 
their ability to quickly recognise the disease enabling 
rapid elimination of all infected birds. To be able to 
recognize a disease quickly, the availability of 
appropriate diagnostic techniques is of paramount 
importance. For countries where the H5N1 has became 
endemic, two types of diagnostic tests are necessary; 
the first type that includes virus isolation and real time 
PCR, is intended for confirmatory, unambiguous 
diagnosis, whereas the second type is the point-of-care, 
or pen-site test intended for rapid diagnosis and to guide 
in determining actions needed to be taken for control or 
eradication of disease (Tarigan 2015). Most tests of the 
second type are immunological test based on the use of 
an antibody to detect the presence of H5N1 antigen. 
To obtain an immunological test with high 
specificity, the use of monoclonal antibody is the 
preferred choice (Ho et al. 2009; Lin et al. 2015). 
However, production of suitable monoclonal antibody 
is expensive and requires high technical skills. 
On the other hand however, the specificity, which is 
the main advantage of monoclonal antibody, may in 
some circumstances become a disadvantage. A 
monoclonal antibody may be so specific that it could 
not tolerate even a minute change (single amino acid 
change) in its epitope and this reduces its sensitivity 
when used in a diagnostic test (Khan 2014; Singh et al. 
2014). Thus, in some instances a polyclonal antibody is 
more suited than a monoclonal antibody, especially 
when the polyclonal antibody has been generated 
against a small, unique antigen. 
Recently, a linear epitope at amino acid residues 
274-281 (CNTKCQTP) in the in HA1 region of the 
haemagglutinin specific for the H5N1 subtype viruses 
has been identified (Prabakaran et al. 2009). The 
epitope was shown to be 100% conserved among 163 
human isolate and 96.9% in 906 avian isolate of H5N1 
viruses. This epitope is not present in H2, H3, H4 and 
H6 - H16 subtypes of influenza viruses, or that the same 
sequence is present only in a small number (2.3%) of 
H1 subtype strains. The CNTKCQTP epitope, in the 
form of a synthetic peptide, immobilized on a 
microtitre-plate reacted in ELISA with sera from birds 
vaccinated with different clades of H5N1 viruses 
(Velumani et al. 2011). The ELISA was reported to be 
100% specific and recommended to be use as a tool in 
surveillance of H5N1 influenza in human and animals 
(Velumani et al. 2011). 
The fact that the CNTKCQTP epitope is specific for 
the haemagglutinin of H5N1 viruses leads us to 
assumption that an antibody raised to that epitope may 
be useful as a diagnostic reagent in particular for pen-
site test intended for rapid H5N1 diagnosis in poultry. 
In this study we generated an antibody by immunizing a 
goat with a synthetic peptide CNTKCQTP and analyzed 
its reactivity against haemagglutinins of different 
subtypes of avian influenza viruses. The ultimate goal 
of this study was to evaluate the potency of the goat-
anti- CNTKCQTP epitope as the main reagent for 
immunodiagnostic test for H5N1 avian influenza. 
MATERIAL AND METHODS 
Peptide 
Two forms of CNTKCQTP peptide were used in 
this study. The first was as a multiple antigenic peptide 
(MAP), a four-symmetrical-branched, 8-amino-acid 
(aa)-long (CNTKCQTP) peptide with unknown purity. 
This aa sequence is found in the haemagglutinin of all 
H5N1 viruses at aa position 274-281 (Prabakaran et al. 
2009; Velumani et al. 2011). The second form was as a 
single linear 17-aa-long (GNCNTKCQTPMGAINSS) 
peptide with >95% purity. This aa sequence is found in 
the haemagglutinin of all H5N1 viruses, at aa position 
272-288 (Prabakaran et al. 2009; Velumani et al. 2011). 
Both peptides were synthetised by VCPBIO Ltd. 
Shenzhen City, China. 
Production and measurement of anti-CNTKCQTP-
antibody 
A one year old, Ettawah-cross breed, male goat was 
purchased from a nearby farm. The goat was kept in a 
stilted, slitter floor isolated from other animal species, 
fed on natural foliage and grass supplemented with 
commercial concentrate (0.1 kg/day). After adapting to 
the laboratory condition for 3 weeks, the goat was 
immunized subcutaneously with 2 mg CNTKQTP MAP 
in complete Freund’s adjuvant. Booster Immunisations 
was carried out at 4 and 8 weeks after the first 
immunization with the same amount of peptide but with 
incomplete Freund’s adjuvant. The fourth immunization 
was carried out 12 week after the first immunization 
with 4 mg CNTKQTP MAP and Quil A adjuvant 
(Superfos Biosector, Denmark) intramuscularly. The 
goat was bled before each vaccination. Two weeks after 
the last immunization, the goat was humanely 
exsanguinated. Serum was aliquoted in 10 ml tubes and 
stored at -20°C. 
The level of anti-CNTKCQTP antibody in the 
serum of the goat before and after immunizations was 
measured with an indirect ELISA. The CNTKQTP 
MAP or GNCNTKCQTPMGAINSS single peptide was 
first diluted in 0.1 M carbonate-bicarbonate buffer (pH 
9.6) at 5 µg/ml. Microtitre plates (Nunc MaxisorpR) 
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were coated with the peptide at 100 µl/well at 4°C 
overnight. After blocking with non-fat skim milk (5 
mg/ml) for 2 hours, serially diluted goat serum in PBS 
containing normal rabbit serum (20 µl/ml) was added 
and incubated at room temperature (25°C) for 2 hrs. 
After washing four times with PBST (0.05% Tween-20 
in PBS, pH 7.2), rabbit- anti-goat-IgG- HRP conjugate 
(Sigma Co. Singapore), diluted in PBS-NRS at 1:4000, 
was added. After washing four times with PBST, 
solution of ABTS [2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulphonic acid) and H2O2 
substrate was added and the absorbance (A420) 
measured with a microtitre-plate reader.  
Measurement of antibody level to CNTKCQTP in 
naïve, vaccinated and challenged chickens 
Sera 
Sera from naïve, vaccinated and H5N1 infected 
chickens were obtained from an experiment conducted 
in our Laboratory and described previous (TARIGAN et 
al., 2015). Briefly, layer chickens were vaccinated with 
a commercial-killed-H5N1 vaccine (Medivac-AI
®
, PT 
Medion, Bandung, Indonesia). Two weeks after the last 
vaccination, birds were challenged with an isolate of 
H5N1 virus (A/Chicken/WestJava/Sbg-29/2007).  Birds 
were bled one day before vacciation, two week after the 
first, second and third vaccination, and every week, 
from 1 to 8 weeks, after challenge. For the current 
study, 20 randomly selected sera were used from each, 
prevaccination (naïve sera), after 1st, 2nd and 3rd 
vaccination (vacinated sera), one week after H5N1 
challenge (early stage infection sera), 2- or 3- weeks 
after challenge (mid stage of infection sera) and >4 
week after infection (late stage of infection sera). In 
addition, sera from two specific pathogen-free (SPF) 
chicken were also included in the assays (PT Vaksindo 
Satwa Nusantara, Indonesia). 
Measurement of antibody level to CNTKCQTP  
Antibody to CNTKCQTP in the bird’s sera was 
measured by an indirect ELISA. Microtitre plate was 
coated with CNTKQTP MAP or 
GNCNTKCQTPMGAINSS single peptide and blocked 
as described previously for the immunized-goat sera. 
Bird’s sera diluted 1 : 100 were added to the plates and 
incubated for 2 hours. After washings four times with 
PBST, rabbit-anti-chicken IgG- HRP- conjugate (Sigma 
Co. Singapore) diluted at 1 : 5000 in PBST was added, 
then incubated at 37°C for 2 hours. In addition to the 
sera from the experimental birds, serum from SPF 
chickens were also added to the plates, as additional 
negative control. After washings, solution of substrate 
and chromogenic ABTS was added and the absorbance 
(A420) meassured with a microtitre plate reader.  
Immunoblotting 
Immunoblot assay was used to analyse the reactivity 
of the CNTKQTP- goat antiserum with the different 
sub-types avian influenza viruses. The first immunoblot 
was between the serum and proteins of whole avian 
influenza viruses. The avian influenza virus subtypes 
available for this study included: (1) 
A/Avian/669/WA/78 (H3N8), (2) A/Grey 
Teal/WA/1840 (H4N4) (3) A/Chicken/WestJava/Sbg-
29/2007(H5N1), (4) (A/Shearwater/Australia/1/72 
(H6N5), (5) A/Duck/Victoria/76/Keysborough (H7N7), 
(6) A/Turkey/Wisconsin/66 (H9N2), (7) CSIRO, 
AAHL GI (H10N7), (8) A/Tern/Aust/75 (H11N9). All 
viruses had been inactivated as they were prepared and 
used in haemagglutination inhibition (HI) test. All 
viruses, except for the H5N1 subtype viruses, were a 
kind gift from Dr. Peter Durr (Australian Animal Health 
Laboratory, Geelong, Australia). Before loading to the 
SDS-PAGE, the inactivated viruses were treated 
according to a previous method (ROSENBERG, 1996b). 
Briefly, 400 µl methanol was added to 100 µl virus 
suspension, vortexed briefly and spun at 14000 x G for 
10 second in a microfuge. After adding 150 µl 
chloroform, the samples were vortexed and spun at 
14000 x G for 10 seconds. After adding 300 µl distilled 
H2O and vortex, the samples were spun at 14000 x G 
for 30 second. The liquid above the protein band at the 
interface between H20 and chloroform was discarded, 
and 300 µl methanol was added. Protein was pelleted at 
14000 x G for 60 second. The supernatant was 
discarded and the protein pellet was dissolved with 100 
µl SDS PAGE sample buffer, heated in boilling water 
for 5 minutes and loaded into the SDS PAGE gel (15 
µl/5-mm-wide well.). 
The second immunoblot was between the 
CNTKQTP-immunised-goat serum and recombinant 
haemagglutinins of all known haemagglutinins H1-H12, 
H14 and H15. The recombinant heamagglutinins, which 
were expressed in mammalian cells were purchased 
from Sinobiologicals Inc. China (Table 1). Each 
recombinant haemagglutinin was dissolved in SDS-
PAGE sample buffer at 200 µg/ml, heated in boiling 
water for 5 minutes and loaded into the SDS PAGE gels 
5 µl/3.4-mm-wide well. 
Protein samples were separated on 10% separating 
gels then transfered onto a nitrocellulose membrane. 
Reversible staining with Ponceau S was carried out to 
confirm the successful transfer and to asses the amount 
of each haemagglutinin on the membrane (Rosenberg 
1996a).  After blocking with skimmed milk (5 mg/ml in 
what?, 2 hours), serum from the CNTKQTP-immunised 
goat diluted at 1 : 200 in PBS containing 5% normal 
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rabbit serum were added and incubated at 25°C for 2 
hours. After washings four times with PBST, rabbit-
anti-goat-IgG- -HRP-conjugate (Sigma Co. Singapore) 
diluted at 1 : 5000 was added and incubated for 2 hrs. 
After washing four times, chromogenic DAB (3,3’-
diaminobenzidine tetrahydrochloride) substrate (H2O2) 
was added to detect bound antibody. 
Sequence analysis 
The alignment of CNTKCQTP epitope with the 
amino acid sequence of haemagglutinins used in this 
study was analysed using a bioinformatics software, 
Genious (Biomatters Ltd, Auckland, New Zealand). 
The amino-acid sequences of the recombinant 
haemagglutinins were download from Genebank 
(NCBI) based on the accession number provided by the 
vendor (Sino Biological Inc.). The similarity or percent 
of identityof of the CNTKCQTP epitope to its analogue 
in each haemagglutinin was determined by the 
percentage of identical amino acid.  
Table 1. Recombinant Haemagglutinin (HA) from Sinobiological Inc., China used in this study 
HA Source of gene Purity 
Mr on SDS-
PAGE/length 
Catalog No. 
H1 
HA1+HA2, 2 aa deletion, uncleaved) from 
A/California/07/2009 (H1N1),  
>95% 
75-85 kDa 
529 aa 
11085-V08H 
H2 HA1+HA2, uncleaved) from (A/Japan/305/1957(H2N2) >97% 
75-85 kDa 
525 aa 
11088-V08H 
H3 
Native, HA1+HA2, uncleaved) from 
A/Brisbane/10/2007(H3N2) 
>97% 
90-100 kDa  
531 aa 
11056-V08H 
H4 
HA1+HA2, uncleaved) from A/Swine/Ontario/01911-
1/99(H4N6) 
>92% 
65-75 kDa  
528 aa 
11706-V08H 
H5 
cleavage site mutated (RESRRKKR→ TETR, HA1+HA2, 
uncleaved) from A/Indonesia/5/2005(H1N1) 
>98% 
70-80 kDa 
531 aa 
11060-V08H1 
H6 
HA1+HA2, uncleaved) from A/northern 
shoveler/California/HKWF115/2007(H6N1) 
>93% 
65 KDa/ 
529 aa 
11723-V08H 
H7 Native, HA1+HA2)  from A/Netherlands/219/03(H7N1) >87% 
59 kDa/ 
536 aa 
11082-V08B 
H8 
HA1+HA2, uncleaved) from A/pintail 
duck/Alberta/114/1979(H8N4) 
>95% 
53.1 kDa  
529 aa 
11722-V08B 
H9 
HA1+HA2, uncleaved) from 
A/chicken/Korea/164/04(H9N8) 
>95%  
58.2 kDa/ 
523 aa 
40183-V08B 
H10 
HA1+HA2, uncleaved) from A/duck/Hong 
Kong/786/1979(H10N3) 
>95% 
60-65 kDa/  
525 aa 
11693-V08H 
H11 
HA1+HA2, uncleaved) from 
(A/mallard/Alberta/294/1977(H11N9) 
>97% 
65-70 kDa/  
528 aa 
11704-V08H 
H12 
HA1+HA2, uncleaved) from A/green-winged 
teal/ALB/199/1991(H12N5) 
>97% 
80-90 kDa/ 
527 aa 
11718-V08H 
H13 
HA1+HA2, uncleaved) from A/black-headed gull/ 
Netherlands/1/00 (H13N8) 
>95% 
60-70 kDa/ 
528 aa 
11721-V08H 
H15 
HA1+HA2, uncleaved) from 
A/duck/AUS/341/1983(H15N8) 
>97% 
75 kDa/ 
534 aa 
11720-V08H 
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RESULTS AND DISCUSSIONS 
Results  
CNTKCQTP antibody 
The titre of antibody to CNTKCQTP epitope in sera 
before and after vaccination with CNTKCQTP MAP is 
presented in Figure 1. As shown in the Figure, no 
antibody was detected in sera before vaccination using 
either CNTKCQTP MAP or 
GNCNTKCQTPMGAINSS single peptide as antigens. 
After four vaccinations the serum had a high titre of 
antibodies as it recognised the CNTKCQTP MAP at 
high 1 : 125,600 dilution. However, the titre with 
GNCNTKCQTPMGAINSS single peptide was much 
lower than the CNTKCQTP MAP. The serum could not 
recognize the single peptide at dilution higher than 1 : 
400. This means that the titer against the MAP peptide 
were higher by 126600/400 = 314 times compared to 
that of single peptides.  
 
Figure 1. Antibody titre in CNTKCQTP MAP antiserum as detected in ELISA using the CNTKCQTP MAP (pre - and post- vac 
MAP) and GNCNTKCQTPMGAINSS single peptides (pre- and post-vac) as antigens. 
 
 
 
Figure 2. Reaction of CNTKCQTP MAP antisera with H5N1whole virus and recombinant H5 haemagglutinin protein in 
immunoblotting. H5N1whole virus proteins (H5N1) and recombinant H5 haemagglutinin (H5) separated on SDS-PAGE 
gel and (A) stained with Coomasie-blue. SDS-PAGE separated protein transferred to a nitrocellulose membrane and reacted 
with (B) normal, pre-immune goat serum (B) and (C) goat CNTKCQTP-MAP antiserum. Arrows = H5N1 haemagglutinin. 
ELISA 
OD 
Serum Dilution 
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Figure 3. Reactivity of recombinant avian influenza haemagglutinins of different subtypes with serum from normal, non-immunised 
(B, D) and CNTKCQTP-MAP immunised goats (C). The amount of each recombinant haemagglutinin transferred onto the 
membrane was equal as shown by the intensity of Ponceau-stained band (A). 
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Figure 4. Reactivity of various subtypes of avian influenza virus proteins with sera from non-immune (A) and CNTKCQTP-MAP 
immunised goat (B). Notice that serum from non-immunised goat recognized strongly a protein band of H6N5 virus 
(arrow), the molecular weight of that protein was smaller than that of haemagglutinin (double head arrows). 
The CNTKCQTP MAP antiserum recognised not 
only the peptide, but also recombinant haemagglutinin 
H5 and haemagglutinin protein from H5N1 virus. The 
antiserum recognized only one of the H5N1-virus 
proteins, which was supposedly haemagglutin because 
its molecular weight was similar to that of the 
recombinant H5. None of H5N1-virus proteins was 
recognised by the CNTKCQTP MAP antiserum (Figure 
2C). Based on the thickness and stain intensity of 
immunoblot band, the recognition of the recombinant 
H5 protein by CNTKCQTP MAP antiserum was much 
stronger than that for H5N1-virus hemagglutinin. The 
differences could be attributed to the bigger amount of 
recombinant H5 than that of H5N1 haemagglutinin 
transferred onto the membrane (Figure 2A). The pre-
immune serum was negative for any antibody to 
H5N1virus as it did not recognized any of the H5N1-
virus proteins and the recombinant H5 proteins (Figure 
2B).  
The CNTKCQTP-MAP anti-serum recognized not 
only recombinant haemagglutinin H5, but also 
haemagglutinins H7, H8, H9, and to a lesser extend, 
H13 (Figure 3C). Serum from pre-immunised goat did 
not recognize haemagglutinin H5, but it recognised 
haemagglutinins H4, H7, H8, H9 and H13 (Figure 3B). 
Serum from a normal, non-vaccinated goat that had 
been kept frozen at -20o for five years, also recognized 
haemagglutinins H7, H8, and H9 (Figure 3D).  
The negative results in the immunoblot assay was 
convincingly attributed to the absence of binding 
between haemagglutinin and specific antibody in the 
sera. It was not due to the absence or limited amount of 
haemagglutinin transferred onto the membrane. Based 
on the thickness of Ponceaou-stained bands, the amount 
of each haemagglutinin transfered onto the 
nitrocellulose membrane was more or less equal (Figure 
3A). The purities of the recombinant haemagglutinins 
which were claimed by the vendor to be >95% for most 
haemagglutinins, and the diversity of the molecular 
weights were approved by the Ponceaou-stained (Table 
1). 
When reacted with whole virus, the CNTKCQTP-
MAP antiserum recognized a protein from H5N1, 
H3N8, H6N5, H7N7, H9N2, H10N7 and H11N9. 
Protein in each virus subtype recognized by the 
antiserum has the same molecular weight, which was 
about 85 kDa. Serum from normal or preimmunised 
goat recognised a H6N6 protein band of MW which is 
of smaller size than expected MW of H6N5 
haemagglutinin (Figure 4, arrow).  
Antibody to CNTKCQTP in chicken 
The presence or absence of antibody to 
CNTKCQTP epitope in H5N1 immune chicken sera is 
presented in Figure 5. The levels of exposure of 
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Figure 5. Antibody levels to CNTKCQTP-MAP in H5N1 immune chicken sera. 0= SPF (specific pathogen-free), 1= prevaccinated, 
2= vaccinated once with killed AI vaccine (MedivacR), 3= vaccinated twice,  4= vaccinated three times,  5= vaccinated then 
challenged with H5N1 and sera collected ≤ 7 dpi (day post infection), 6= vaccinated then challenged, sera collected 14-21 
dpi, 7= vaccinated then challenged, sera collected ≥35 dpi. Bars= mean and 95% confidence interval of the means from 20 
birds (groups 1-70, and from 3 birds (group 0). 
Table 2. Alignment CNTKCQTP epitope with analogue epitopes in haemagglutinin 
Haem-
agglutinin 
Subtype Gene Bank Acc No. Amino acid sequence Position Identity (%) 
H1 H1N1 ACP44189.1 CNTTCQTP 292-299 87.5 
H2 H2N2 AAA43185.1 CETKCQTP 288-295 87.5 
H3 H3N2 ABW23353.1 CNSECITP 293-300 62.5 
H4 H4N6 AAG17429.1 CVSKCHTD 291-298 50 
H5 H5N1 ABW06108.1 CNTKCQTP 290-297 100 
H6 H6N1 ACE81692.1 CDATCQTI 292-299 50 
H7 H7N7 AAR02640.1 CEGDCYHS 293-300 25 
H8 H8N4 AAG38554.1 CNTKCQTY 298-305 87.5 
H9 H9N8 ABH12262.1 CVVQCQTE 286-293 50 
H10 H10N3 BAF46762.1 CESKCFWR 287-294 37.5 
H11 H11N9 ABB87228.1 CSTKCQSE 290-297 62.5 
H12 H12N5 ABB88110.1 CVTECQLN 290-297 50 
H13 H13N8 AAV91212.1 CNTKCQTS 290-297 87.5 
H15 H15N8 ABB88132.1 CEGECFYS 296-303 25 
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chickens to H5N1 virus ranged from being anybody 
free as represented by SPF sera (group 0) to the those 
being exposed and represented by sera from chickens 
vaccinated multiple times and sera obtained following 
challenged with live H5N1 virus. The level of antibody 
to CNTKCQTP, as indicated by the ELISA’s OD, in the 
SPF chicken was marginal lower compared to other 
groups. There were no differences in ODs between sera 
from pre-vaccinated (group 2) and post vaccinated birds 
(groups 2, 3, 4), and between pre-vaccinated (group 2) 
and post-challenged birds (groups 5, 6, 7). The low 
ELISA ODs indicated the absence of antibody to 
CNTKCQTP in all groups of the chicken.  
Amino-acid sequence alignment 
Alignment of CNTKCQTP epitope with analogue 
epitope in the amino acid sequence of haemagglutinins 
used in this study is presented in Table 2. Except for 
H5, none of the haemagglutinin had 100% similarity 
with the CNTKCQTP epitope. Four haemagglutinins 
(H1, H2, H8 and H13) had analogue epitopes with only 
one amino acid different with the CNTKCQTP epitope. 
The analogue epitope in the haemagglutinins H7 and 
H15, which had had only two identical amino acids, 
were the most divergent. 
Discussion 
This study shows that the linear CNTKCQTP 
epitope, which is located in the amino acid residue 274-
281 of H5N1 haemagglutinin is immunogenic as high 
antibody titre was obtained following immunization 
with the CNTKCQTP MAP. The goat-CNTKCQTP-
antisera would be useful as a reagent in the 
development of diagnostic test for H5N1 avian 
influenza because it recognized H5N1 haemagglutinin, 
either as a recombinant protein or as a native protein 
present in the H5N1 virus particle. The production of 
goat-CNTKCQTP-antisera was technically simple and 
inexpensive and this is important to overcome obstacles 
of using CNTKCQTP-monoclonal antibody that is 
expensive for routine diagnostic use (Velumani et al. 
2011). 
Interest in developing diagnostic tools for influenza 
has been great because the disease has been one of the 
most important diseases in human and animals. Point-
of-care (POC) tests, most of which belong to the group 
of rapid immunological tests, have been the most 
widely developed tests because their benefits in the 
control of influenza either in animals or in human have 
been proven. In human, the ability to confirm that an 
illness is or is not caused by an influenza virus, using a 
POC test, can be a lifesaving undertaking because 
effective anti-influenza drugs are available (Gavin & 
Thomson 2003). The importance of a POC test in the 
control measure of HPAI has been demonstrated in the 
PDSR (participatory Disease Survellance and 
Response) project, a successful HPAI control program 
in sector-4 poultry in Indonesia (Hawkes et al. 2014; 
Tarigan 2015). 
The accuracy of an immunological test depends on 
the specificity of antibody used in the test. Being very 
specific, because it recognized only one epitope in the 
antigens, monoclonal antibodies have been used widely 
in the development of POC tests. For this reason, a 
large number of attempts have been made to produce 
monoclonal antibodies against influenza viruses (Wang 
et al. 2000; Rai et al. 2010; Wei et al. 2011; Bhat et al. 
2013). Sometimes, however, a monoclonal antibody is 
too specific that it can not tolerate even a minor 
variation in its epitope, which reduce its diagnostic 
sensitivity when used in dignostic assay (Khan 2014; 
Singh et al. 2014).  
The CNTKCQTP -polyclonal antibody produced in 
this study was also expected to be highly specific 
because its was produced against  a short peptide 
expected to contain only a few antigenic epitopes. 
Additionaly polyclonal antibodies are considered to be 
more tolerant of antigenic variation in the epitope, and 
therefore when used in immunoassy, it should have 
higher sensitivity than monoclonal antibody.  
As shown in this study, the polyclonal antibody no 
longer recognized the sequence (analogous epitope) 
even only one amino acid  different, either the 
difference in the middle (haemagglutinins H1 and H2) 
or at the end of the sequence (haemagglutinins H8 and 
H13). This results may indicate that the CNTKCQTP-
MAP used to immunised the goat contains only a single 
epitope. 
Previous study reported that monoclonal antibody to 
CNTKCQTP epitope, 5F8,  had high specivicity 
(Prabakaran et al. 2009) and when used in an epitope-
blocking ELISA against recombinat H5N1 
haemagglutinin (HA0), the ELISA could identify 
specifically chicken that had been vaccinated against 
H5N1 virus and no cross reactions were observed with 
subtypes H1-H4, H6-H16 influenza viruses.  
Unlike the 5F8-monoclonal antibody, the 
CNTKCQTP-MAP polyclonal antibody produced in 
this study was not specific for haemagglutinin of H5N1, 
because it also recognised haemagglutinin of other AIV 
subtypes, including H3N8, H4N4, H6N5, H7N7, H9N2, 
H10N7 and H11N9. 
The use of recombinant haemagglutinins in 
immunoblot assay in the present study failed to 
establish the specificity of CNTKCQTP-MAP 
antiserum. This was because the goat used in the 
antibody production already had antibody to 
hemagglutinin of some isolates especially H7, H8 and 
H9 before immunisation. It is unknown how common it 
is normal or non-vaccinated goats being seropositive to 
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H7, H8 and H9 haemagglutinins. However, the fact that 
serum from a non-immunised, heathy goat, collected 
five years ago, was also positive to those  
haemagglutinins when tested similarly may indicates 
that the condition is common. However, It is unknown 
whether the seropositivity was caused by infection with 
related subtypes of influenza-viruses or induced by 
other immunologically cross-reactive agents . The later 
possibility was more likely because it was supported by 
the results of other immunoblot assay using whole 
inactivated-influenza viruses in which the same non-
vaccinated serum did not recognise haemagglutinin 
from H7N7 and H9N2 subtypes influenza viruses.  
Before immunisation with the CNTKCQTP -MAP, 
the goat had been tested and it was seronegative to 
H5N1 virus. We did not, however,  test the goat against 
hemagglutinin of other subtypes. In addition to our 
failure to envisage the possibility of the goat 
seropositive to haemagglutinin of other serotypes, the 
array of recombinant haemagglutins used in detection 
of the antibodies was not available untill the goat 
exsanguinated. This study, therefore, convinced the 
vital importance of testing animals to be used in the 
production of antiserum to be tested against 
haemagglutinin of subptypes all influenza virus before 
used. 
The second aspect of the CNTKCQTP-peptide 
evaluated in this study, the use of the linear peptide in 
indirect ELISA to detect antibody, also generated 
results that are different to those of previous study 
(Velumani et al. 2011). In that study, the peptide-
ELISA was able to specifically identify chicken that 
had been vaccinated with H5N1 virus of various clades. 
In the present study, on the other hand, a similar ELISA 
could not detect the present of specific antibody in 
chicken that had been vaccinated once, twice, thrice, or 
even in vaccinated chicken that had been challenged 
with a life H5N1 virus. There are three things that were 
different between ELISA in this study and that in 
previous study. First, the concentration of peptide used 
to coat the microtitre plate was 5 µg/ml in this study 
and 10 µg/ml in previous one. We are convinced that 
this concentration difference could not attributed to 
differences in the results because in our preliminary 
experiment, we found that no differences between both 
concentrations (data not presented). Second, in this 
study non-fat-skimmed milk was used as a blocking 
reagent whereas in previous study, bovine serum 
albumin was used. In our previous study, we found that 
non-fat-skimmed milk was effective as blocking agent 
and therefore the blocking reagent could not also be 
attributed to the differences result of this study and 
previous study (Tarigan et al. 2015). Third, in this study 
the chicken were immunised with a commercial H5N1 
vaccine, whereas, in previous study the vaccine was 
prepared by the authors themselves. Because the 
vaccine was prepared by the authors themselves, the 
purity and the amount of immunogen contained in the 
vaccine were known with certainty. The purity and the 
amount of immunogen in the commercial vaccine in the 
present study were unknown. 
In summary, immunisations of goat with the 
CNTKCQTP epitope, in the form of MAP, produced 
antibody that recognised H5 haemagglutinin but only 
H5N1 virus. The antibody is useful as the main reagent 
in development of rapid test for H5N1 avian influenza. 
Some apparently pre-immunised goats are seropostive 
for some influenza haemagglutinins, therefore testing 
goats against all influenza haemagglutinins before used 
for antibody production is vitally important. This study 
fail to demonstrate the presence of antibody to 
CNTKCQTP epitope in chicken that had been 
vaccinated or infected with H5N1 virus. 
CONCLUSION 
High titre antibody to CNTKCQTP epitope was 
produced by immunising goat with CNTKCQTP MAP.  
The serum recognised haemagglutinin H5 and therefore 
is useful as a reagent for detection of H5N1 virus. 
However, unlike CNTKCQTP monoclonal antibody 
generated previously, the serum is not specific for 
H5N1 haemagglutinin as it also recognises 
haemagglutinin of other influenza virus subtypes. Some 
apparently pre-immunised goats are seropostive for 
some influenza haemagglutinins, therefore testing goats 
against all influenza haemagglutinins before used for 
antibody production is vitally important. ELISA using 
peptide containing the epitope sequence, 
GNCNTKCQTPMGAINSS, cannot be used to detect 
anti-H5N1 antibody in chicken immunised with 
commercial-H5N1 vaccine. 
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